BioMarin to Participate in Four Upcoming Virtual Investor Conferences
Rhea-AI Summary
BioMarin Pharmaceutical (NASDAQ: BMRN) will participate in four upcoming virtual investor conferences. Live audio webcasts of the presentations can be accessed via their website, with archived versions available for a limited time post-conference. BioMarin is known for developing therapies for serious rare disorders, boasting a portfolio of six commercial products and several clinical candidates. Investors can find more information about the company and its innovations at www.biomarin.com.
Positive
- None.
Negative
- None.
News Market Reaction – BMRN
In the trading session that priced this news, BMRN gained 1.42%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAFAEL, Calif., Feb. 24, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301234450.html
SOURCE BioMarin Pharmaceutical Inc.